Lipid dysfunction and adrenomedullin expression in omental versus subcutaneous adipose tissues in diabetic pregnancies
Open Access
- 7 April 2022
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 17 (4) , e0265419
Abstract
Gestational diabetes mellitus (GDM) is one of the most common complications of pregnancy but the underlying mechanism remains obscure. The aims of this study are to examine if omental adipose tissue (OMAT) and subcutaneous AT (SCAT) differentially express proinflammatory and lipid metabolic adipokines, and if so, whether their regional differences have implications on lipid metabolism in GDM. Paired samples of OMAT and SCAT were excised from pregnant women in scheduled Cesarean sections with non-obese (NOBS), obese (OBS) and GDM. The results showed that the mRNA of monocyte chemoattractant protein (MCP)-1, macrophage marker CD68, and cytokines IL-6, IL-8, and TNF-α are increased in OMAT from GDM women compared to that in NOBS and OBS women (P<0.05). Glucose and TNF-α dose-dependently enhanced ADM and its receptor components CRLR and RAMPs in human adipocytes. Immunofluorescence showed that ADM and its receptor components are higher in OMAT from GDM women compared to non-GDM women. Further, basal lipolysis was greater in OMAT than in SCAT and ADM stimulates further glycerol release in OMAT, but not in SCAT, and these increases are reduced by ADM antagonist, ADM22-52. We therefore conclude that elevated ADM and its receptor expressions by OMAT, but not by SCAT appear to contribute to the lipid dysregulation in GDM women, and manipulation of ADM may represent one of the novel approaches in minimizing the risk of GDM-related fetal overgrowth.Keywords
Funding Information
- National Institutes of Health (HL-102866)
- National Institutes of Health (HL-58144)
This publication has 44 references indexed in Scilit:
- Omentin-1 Is Decreased in Maternal Plasma, Placenta and Adipose Tissue of Women with Pre-Existing ObesityPLOS ONE, 2012
- Disturbances in lipid metabolism in diabetic pregnancy – Are these the cause of the problem?Best Practice & Research Clinical Endocrinology & Metabolism, 2010
- Concomitant expression of adrenomedullin and its receptor components in rat adipose tissuesAmerican Journal of Physiology-Endocrinology and Metabolism, 2005
- Studies on the Effects of the N-Terminal Domain Antibodies of Calcitonin Receptor-Like Receptor and Receptor Activity–Modifying Protein 1 on Calcitonin Gene-Related Peptide-Induced Vasorelaxation in Rat Uterine Artery1Biology of Reproduction, 2004
- Placental and Fetal Growth and Development in Late Rat Gestation Is Dependent on Adrenomedullin1Biology of Reproduction, 2002
- Fetomaternal Adrenomedullin Levels in Diabetic PregnancyHormone and Metabolic Research, 2001
- Is adrenomedullin a causal agent in some cases of type 2 diabetes?Peptides, 1999
- Differences in Lipolysis between Human Subcutaneous and Omental Adipose TissuesAnnals of Medicine, 1995
- Adrenomedullin: A Novel Hypotensive Peptide Isolated from Human PheochromocytomaBiochemical and Biophysical Research Communications, 1993
- Adipose Expression of Tumor Necrosis Factor-α: Direct Role in Obesity-Linked Insulin ResistanceScience, 1993